GSK turns to insider to be next CEO — and the stock rallies
1. GSK appoints Luke Miels as new CEO starting January 1. 2. Company shares rose 4% in response to leadership change. 3. Miels aims to drive growth ahead of key patent expiry in 2028. 4. GSK maintains a 2031 sales target of over £40 billion. 5. Walmsley oversaw significant company transformations during her tenure.